S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology Stock Forecast, Price & News

$84.72
+0.87 (+1.04%)
(As of 11/26/2021 12:00 AM ET)
Add
Today's Range
$83.65
$87.30
50-Day Range
$83.31
$106.99
52-Week Range
$73.94
$113.06
Volume
38,360 shs
Average Volume
107,413 shs
Market Capitalization
$216.04 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BIB News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares Ultra Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIB
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$193.76 million
Average Daily Volume$162.19 thousand
Discount/Premium-0.09%

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of BIB

Currency Exposure of BIB

Sector Exposure of BIB

Industry Exposure of BIB













ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Frequently Asked Questions

How has ProShares Ultra Nasdaq Biotechnology's stock been impacted by Coronavirus?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $47.23 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIB stock has increased by 79.4% and is now trading at $84.72.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V).

What is ProShares Ultra Nasdaq Biotechnology's stock symbol?

ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIB."

Who are ProShares Ultra Nasdaq Biotechnology's major shareholders?

ProShares Ultra Nasdaq Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Howard Capital Management Inc. (8.23%), Geneos Wealth Management Inc. (7.96%), OLD Mission Capital LLC (0.98%), Toth Financial Advisory Corp (0.87%), Orion Portfolio Solutions LLC (0.54%) and Citadel Advisors LLC (0.00%).

Which major investors are selling ProShares Ultra Nasdaq Biotechnology stock?

BIB stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Vontobel Holding Ltd., United Maritime Capital LLC, and Morgan Stanley.

Which major investors are buying ProShares Ultra Nasdaq Biotechnology stock?

BIB stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Geneos Wealth Management Inc., OLD Mission Capital LLC, Orion Portfolio Solutions LLC, Toth Financial Advisory Corp, Wolverine Trading LLC, Traynor Capital Management Inc., and Destiny Wealth Partners LLC.

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

One share of BIB stock can currently be purchased for approximately $84.72.

How much money does ProShares Ultra Nasdaq Biotechnology make?

ProShares Ultra Nasdaq Biotechnology has a market capitalization of $216.04 million.

What is ProShares Ultra Nasdaq Biotechnology's official website?

The official website for ProShares Ultra Nasdaq Biotechnology is www.proshares.com.

Where are ProShares Ultra Nasdaq Biotechnology's headquarters?

ProShares Ultra Nasdaq Biotechnology is headquartered at SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States.

How can I contact ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The exchange traded fund can be reached via phone at +1-240-4976400.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.